Mariner
MRNA icon

Mariner’s Moderna MRNA Stock Holding History

Mariner’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Buy
+38,127
New +$1.97M ﹤0.01% 1326
2025
Q4 		– Sell
-10,456
Closed -$270K – 3707
2025
Q3 		$270K Sell
10,456
-11,157
-52% -$311K ﹤0.01% 2901
2025
Q2 		$596K Sell
21,613
-6,756
-24% -$178K ﹤0.01% 2196
2025
Q1 		$806K Buy
28,369
+11,242
+66% +$399K ﹤0.01% 1838
2024
Q4 		$712K Sell
17,127
-5,060
-23% -$242K ﹤0.01% 1891
2024
Q3 		$1.48M Sell
22,187
-7,234
-25% -$664K ﹤0.01% 1353
2024
Q2 		$3.49M Buy
29,421
+2,186
+8% +$277K 0.01% 865
2024
Q1 		$2.9M Buy
27,235
+3,903
+17% +$393K 0.01% 933
2023
Q4 		$2.32M Buy
23,332
+3,090
+15% +$260K 0.01% 988
2023
Q3 		$2.09M Buy
20,242
+996
+5% +$111K 0.01% 954
2023
Q2 		$2.34M Sell
19,246
-1,162
-6% -$155K 0.01% 911
2023
Q1 		$3.12M Sell
20,408
-1,780
-8% -$294K 0.01% 782
2022
Q4 		$3.99M Buy
22,188
+2,086
+10% +$341K 0.01% 686
2022
Q3 		$2.38M Buy
20,102
+2,776
+16% +$421K 0.01% 705
2022
Q2 		$2.48M Sell
17,326
-1,047
-6% -$150K 0.01% 647
2022
Q1 		$3.17M Buy
18,373
+3,637
+25% +$612K 0.01% 604
2021
Q4 		$3.74M Buy
+14,736
New +$4.31M 0.02% 502
2021
Q3 		– Sell
-11,176
Closed -$2.63M – 1008
2021
Q2 		$2.63M Sell
11,176
-1,364
-11% -$244K 0.02% 431
2021
Q1 		$1.64M Buy
12,540
+418
+3% +$60.6K 0.01% 500
2020
Q4 		$1.27M Buy
12,122
+974
+9% +$98.5K 0.01% 521
2020
Q3 		$789K Buy
+11,148
New +$777K 0.01% 543
2020
Q2 		– Sell
-13,146
Closed -$394K – 748
2020
Q1 		$394K Buy
+13,146
New +$302K ﹤0.01% 615

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Mariner's MRNA Position: Q2 2026 in Review

Mariner opened a new position in Moderna (MRNA) in Q2 2026: 38,127 shares worth $2.67M. The stake represents ﹤0.01% of the portfolio and ranks #1326 among its holdings. This is a return to the name: Mariner previously reported a position in MRNA as recently as Q3 2025.

Mariner first reported a position in MRNA in Q1 2020 and has held it in 22 quarters since. The position peaked at $3.99M in Q4 2022. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Mariner held 38,127 shares of Moderna worth $2.67M as of Q2 2026.
  • Moderna was a new Mariner position in Q2 2026.
  • Moderna made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1326 holding.
  • Mariner first reported a position in Moderna in Q1 2020 and has held it in 22 quarters since.
  • Mariner's Moderna position peaked at $3.99M in Q4 2022.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.